Found 305 articles for: "alopecia"
TikTok and Dermatology: Questioning the Data
August 2024 | Volume 23 | Issue 8 | Features | 7956 | Copyright © August 2024
The Treatment of Psoriasis With Intramuscular Triamcinolone
August 2024 | Volume 23 | Issue 8 | Features | 7866 | Copyright © August 2024
Challenges in Adult Acne and the Role of Skin Care in Managing the Condition
August 2024 | Volume 23 | Issue 8 | Original Article | 8471 | Copyright © August 2024
Background: Acne vulgaris is a complex, multifactorial, inflammatory skin condition. Although frequently presented at dermatology clinics, the literature on adult acne is scarce,...
Read MoreUnderrepresentation of Skin of Color in Google Images Search of Common Skin, Hair, and Nail Conditions
July 2024 | Volume 23 | Issue 7 | Editorials | e161 | Copyright © July 2024
An Open-label Study to Investigate the Efficacy and Tolerability of Dapsone Gel, 7.5% in the Treatment of Acne Vulgaris in Men and Women With Skin of Color
June 2024 | Volume 23 | Issue 6 | Original Article | 410 | Copyright © June 2024
Introduction: Acne vulgaris is a common skin disease prevalent in skin of color patients. Studies have demonstrated that dapsone gel, 7.5% (Aczone) used once daily is effective, ...
Read MoreAnifrolumab for the Dermatologist
June 2024 | Volume 23 | Issue 6 | Features | 489 | Copyright © June 2024
Blue Light Effects on the Skin: A Post-2015 Update
June 2024 | Volume 23 | Issue 6 | Original Article | 472 | Copyright © June 2024
The debate surrounding the benefits versus harms of blue light have become a topic of interest recently due to increased exposure. Blue light therapy has been utilized with some success in a vari...
Read MoreRuxolitinib 1.5% Topical Cream for the Treatment of Pediatric Alopecia Areata
May 2024 | Volume 23 | Issue 5 | Case Reports | 378 | Copyright © May 2024
Alopecia areata (AA) is a common autoimmune disorder. Although its pathogenesis is not fully understood, AA involves CD8 T cell-mediated destruction of the hair follicle. Several treatment option...
Read MoreEyebrow and Eyelash Loss in Patients With Cancer
May 2024 | Volume 23 | Issue 5 | Original Article | 327 | Copyright © May 2024
Though it is widely acknowledged that cancer treatments cause hair loss on the scalp, there are limited data on how they affect eyebrow and eyelash hairs. Patients with eyebrow and eyelash loss, ...
Read MoreBeyond the Label: Real-World Side Effects Experienced With FDA-Approved Drugs for Non-Melanoma Skin Cancers
May 2024 | Volume 23 | Issue 5 | Original Article | 301 | Copyright © May 2024
With immunotherapy historically focused on cutaneous melanoma, there has been a new wave of systemic medications available for treating non-melanoma skin cancers including basal cell carcinoma (B...
Read MoreHydroxychloroquine-Induced Nonthrombocytopenic Purpura: A Case Series
May 2024 | Volume 23 | Issue 5 | Case Reports | e124 | Copyright © May 2024
Hydroxychloroquine (HCQ) is a disease-modifying anti-rheumatic medication for the treatment of various autoimmune conditions. A rare side effect of HCQ is thrombotic thrombocytopenic purpura (TTP). We...
Read MoreExpression of IL-4 in Tumors: A Safety Surrogate to Predict Cancer Survival Associated With Biologic Therapies
April 2024 | Volume 23 | Issue 4 | Editorials | e118 | Copyright © April 2024
Mitogen-Activated Protein Kinase Inhibitor-Induced Inflammatory Alopecia in Woman With Ovarian Cancer
April 2024 | Volume 23 | Issue 4 | Case Reports | e102 | Copyright © April 2024
Inflammatory alopecia is an increasingly reported side effect of targeted cancer therapies. Here we report one case of inflammatory alopecia secondary to mitogen-activated protein kinase kinase (...
Read MoreBeyond Wrinkles: A Comprehensive Review of the Uses of Botulinum Toxin
March 2024 | Volume 23 | Issue 3 | Original Article | 173 | Copyright © March 2024
Background: Botulinum neurotoxin (BoNT) exhibits inhibitory effects on the neuromuscular junction, and its use is well established in cosmetic dermatology. Our review aims to ana...
Read MoreHighlighting the Link Between Lichen Planus Pigmentosus and Frontal Fibrosing Alopecia
March 2024 | Volume 23 | Issue 3 | Features | 196 | Copyright © March 2024
Efficacy of Low-Dose Spironolactone for Hair Loss in Women
March 2024 | Volume 23 | Issue 3 | Editorials | e91 | Copyright © March 2024
Safety and Efficacy of Minoxidil Treatment in Scarring Alopecia: A Scoping Review
March 2024 | Volume 23 | Issue 3 | Original Article | 146 | Copyright © March 2024
Background: Topical minoxidil (TM) has been a cornerstone in treating various hair loss disorders, while low-dose oral minoxidil (LDOM) is emerging as an effective alternative. D...
Read MoreSurvey of the Prices of Topical Compounded Medications for Alopecia in the Tri-State Area
March 2024 | Volume 23 | Issue 3 | Original Article | 168 | Copyright © March 2024
Background: Currently, there is only one topical medication approved by the U.S. Food and Drug Administration for alopecia, minoxidil 2.5% and 5%. With limited options, dermatolo...
Read MoreSurvey of Dermatology Practitioners' Opinions and Prescribing Habits of Oral Minoxidil for the Treatment of Androgenetic Alopecia
March 2024 | Volume 23 | Issue 3 | Original Article | 136 | Copyright © March 2024
Background: Utilization of low-dose oral minoxidil has increased in recent years in association with several clinical studies that have shown its efficacy in treating androgeneti...
Read MoreExamining the Uncertainties Surrounding Exosome Therapy in Androgenetic Alopecia: A Call for Evidence-Based Practice
March 2024 | Volume 23 | Issue 3 | Features | e86 | Copyright © March 2024
Media and other results for: "alopecia"